SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: johny who wrote (322)12/4/1997 11:28:00 PM
From: Andreas  Read Replies (1) of 2068
 
I certainly hope you're right Johny. I am a recent shareholder to OXHP and although today requires some explaining I will continue to stay the course based upon (1) strong balance sheet, (2) good financial ratios, (3) a belief that the market has substantially overreacted to OXHP's short-term problems; (4) a fundamentally sound business with (5) good to excellent growth potential. The key to me, as a neophyte in OXHP is whether or not this management has the talent, insight and skill to fix the problems as quickly as possible. The officers and directors have a fiduciary obligation to the shareholders first. This obligation requires, in my view, open and frequent disclosures to its shareholders, of what management is doing in detail to get OXHP back on course. Thus far my grade in this department is a C-.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News